Friday, 15 Dec 2017

Autoimmune/Lupus

Datesort ascending Type Title Save
05 Nov 2017 Social RT @Lupusdoc: IFN kappa, a key driver of enhanced inflamm responses in skin lupus @RheumNow #ACR17 #897
05 Nov 2017 Social RT @KDAO2011: LLDAS (lupus low dz activity state) definition more meaningful in SLE clinical trials #ACR17 @rheumnow #888 https://t.co/Dk2u…
05 Nov 2017 Social RT @Janetbirdope: @RheumNow Lupus costs money prior to diagnosis . Maybe comorbidities and symptoms account for this. #acr17 @rheumnow #199…
05 Nov 2017 Social RT @isa75012: TIF1 mutations and loss of heterozygosity: TIF1 is to myositis what RNPpolymerase3 is for systemic sclerosis in re: cancer.#A…
05 Nov 2017 Social RT @DrRachelTate: Pre-clinical assoc between serologic measures of EBV reactivation and SLE disease transition. #ACR17 @RheumNow #910 https…
05 Nov 2017 Social RT @KDAO2011: Vaccination of juvenile SLE w/ hepA vaccine won’t flare SLE and still garner good response #ACR17 @rheumnow #369
05 Nov 2017 Social RT @_connectedcare: Anti NXP-2 antibodies identify 85% of those with cancer associated dermatomyositis #ACR17 @rheumnow https://t.co/6BXnFC…
05 Nov 2017 Social RT @_connectedcare: Inclusion body myositis often presents with finger flexor weakness & knee extensor weakness #ACR17 @rheumnow https://t.…
05 Nov 2017 Social RT @_connectedcare: Features in someone with weakness which would lead you away from diagnosing myositis #ACR17 @rheumnow https://t.co/Lt30…
05 Nov 2017 Social RT @Lupusdoc: 4 SLE "you need to be an expert in immunology, rheumatology + everything else" E Hess @RheumNow #ACR17
05 Nov 2017 Social RT @DrBhana: Pathology driving treatment of Lupus Nephritis #ACR17 https://t.co/hE179y4WBS
05 Nov 2017 Social RT @doctorakerkar: Pathology driven treatment protocol for #Lupus nephritis #ACR17 @rheumnow https://t.co/6euyeP56cS
05 Nov 2017 Social RT @_connectedcare: Critical Illness Myopathy occurs in 30% of those ventilated & immobilized in ICU for 5 or more days #ACR17 @rheumnow ht…
05 Nov 2017 Social RT @_connectedcare: Here’s a list of COMMON malignancies in Dermatomyositis #ACR17 @rheumnow https://t.co/mEmJPOm7fh
05 Nov 2017 Social RT @DrRachelTate: splenic FDG uptake is significantly elevated in patients with MAS compared sepsis. #ACR17 @RheumNow #245 https://t.co/ce8…
05 Nov 2017 Social RT @_connectedcare: Hydroxychloroquine prevents Thrombosis in SLE. Remember this. #ACR17 https://t.co/1IdzYwx9FR
04 Nov 2017 Social RT @_connectedcare: Risk factors for APS in those who have antiphospholipid antibodies #ACR17 https://t.co/5i1BnS9qmD
04 Nov 2017 Social RT @KDAO2011: Dr M Petri #ACR17 "Only 25% of SLE pts will have persistent APAs." @rheumnow
04 Nov 2017 Social RT @KDAO2011: Dr M Petri #ACR17 Livedo racemosa highly assc w/thrombosis @rheumnow https://t.co/MD7GUBLJ2Z
04 Nov 2017 Social RT @KDAO2011: Dr M Petri #ACR17 newer class of dz the Complementopathies: PNH, aHUS, and catastrophic APS @rheumnow